Home Equities Score Why Reviva Pharmaceuticals Holdings Inc (RVPH) stock soared in the after-hours on...

Why Reviva Pharmaceuticals Holdings Inc (RVPH) stock soared in the after-hours on Friday?

Reviva Pharmaceuticals Holdings Inc (RVPH) shares gained 5.26% in after-hours on Friday, July 2, 2021, and closed the week at $5.10 per share. Earlier in the morning session of Friday, RVPH’s stock lost 4.80% to close Friday’s session at $4.56. RVPH shares have fallen 56.57% over the last 12 months, and they have moved down 8.62% in the past week. Over the past three months, the stock has lost 17.39%, while over the past six months, it has declined 47.86%.

>> 7 Top Picks for the Post-Pandemic Economy << 

Inauguration on Russell Microcap® Index

On June 28, 2021, Reviva Pharmaceuticals Holdings, Inc joined the broad-market Russell Microcap® Index after the Russell U.S. Indexes annual reconstitution. The updated Index became effective after the U.S. equity market opened on Monday, June 28, 2021.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Read More

Pricing of Upsized $30 Million Underwritten Public Offering

On May 26, 2021, Reviva Pharmaceuticals Holdings, Inc announced the pricing of its upsized underwritten public offering of 8,000,000 shares of its common stock and accompanying investor warrants to purchase up to 6,000,000 shares of common stock. The investor warrants will be immediately exercisable at an exercise price of $4.125 per share of common stock and will expire five years from the date of issuance. The underwriters will get a 45-day option to purchase an additional 1,200,000 shares of common stock and/or investor warrants to purchase up to an additional 900,000 shares of common stock at the public offering price less discounts and commissions.

Developing of next-generation Antipsychotic Drug

On April 26, 2021, Revivaannouncedthe full details of its Phase 2 clinical trial for its lead drug candidate, RP5063 (brilaroxazine) for Acute Schizophrenia.

Reviva lead drug candidate Brilaroxazine(RP5063) aims to address Schizophrenia.

Schizophrenia is the most common psychotic disease with a global prevalence in about 1% of the population, affecting approximately 3.5 million people in the U.S. and 20 million globally.

Brilaroxazine is Reviva’s lead asset which had demonstrated efficacy as well as safety for the treatment of schizophrenia in Reviva’s Phase 2 clinical trials in over 230 patients.

Recent financial results announcement

On March 22, 2021, Reviva Pharmaceuticals Holdings, Inc released its financial results for 2020.

FY2020 financial highlights

  • Reviva Pharmaceuticals suffered a net loss of approximately $3.8 million, or $1.24 per share, for the year ended December 31, 2020, compared to a net loss of approximately $847,000, or $0.31 per share in FY 2019.
  • Financing activities provided net cash of $12.5 million in FY 2020, which is primarily related to proceeds of $9.4 million from the close of the merger and $3.1 million from the issuance of convertible promissory notes.
  • The Company’s cash and cash equivalents totaled approximately $8.8 million on December 31, 2020, compared to approximately $193 as of December 31, 2019.

    >> 7 Top Picks for the Post-Pandemic Economy << 

Conclusion

There is no recent news that could explain RVPH mixed performance on Friday. we hope that RVPH stock will continue its positive momentum after the long weekend

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Energous Corporation Inc. (WATT) stock declines during after-market. Here’s to know why?

Energous Corporation Inc. (WATT) stock gained by 7.05% at last close whereas the WATT stock price plunged by 7.82% in the after-hours trading session....

AMAZON Inc. (AMZN) stock fell during after-market. Here’s the update

Amazon Inc. (NASDAQ: AMZN) stock plunged by 0.84% at last close however moving ahead the AMZAN share price also declines by 7.44% in the...

Cocrystal Pharma Inc. (COCP) stock soars during current market. Here’s what you should know

Cocrystal Pharma Inc. (NASDAQ: COCP) stock gains by 17.44% in the current market trading session. Cocrystal Pharma, Inc. is a clinical-stage biotechnology firm focused...

Why did Corvus Pharmaceuticals Inc. (CRVS) stock soar on Wednesday?

Corvus Pharmaceuticals Inc. (CRVS) shares surged 9.17% in after-hours on Wednesday, July 28, 2021, and closed the daily trading at $2.38. in the regular...

Havertys Furniture Companies Inc. (HVT) stock gains during after-hour trading, Here’s to know why?

Havertys Furniture Companies Inc. (NASDAQ: HVT) stock declined by 0.39% at last close whereas the HVT stock price gains by 4.6% in the after-hours...

ImmunoPrecise Inc. (IPA) stock fell during pre-market. What’s the update?

ImmunoPrecise Inc. (NASDAQ: IPA) stock declined by 8.39% at last close while the IPA stock-price plunge by 4.87% in pre-market as well. ImmunoPrecise is...

ECMOHO Ltd. (MOHO) stock plunged during pre-market. Let’s see what’s happening?

ECMOHO Ltd. (NASDAQ: MOHO) stock gained by 7.05% at last close, while during pre-market MOHO stock has been seen declining by 7.75%. In China's...

Synthetic Biologics Inc. (SYN) stock plunged during pre-market. Here’s what you should know?

Synthetic Biologics Inc. (NASDAQ: SYN) stock gained by 8.09% at last close whereas the SYN stock price declines by 0.54% in the pre-market trading....

Related News

UXIN stock declines during current market trading. What’s driving it low?

Uxin Ltd. (NASDAQ: UXIN) stock declines by 3.41% during current market trading. In China, Uxin Limited is a prominent online used vehicle dealer with...

Synthetic Biologics Inc. (SYN) stock plunged during pre-market. Here’s what you should know?

Synthetic Biologics Inc. (NASDAQ: SYN) stock gained by 8.09% at last close whereas the SYN stock price declines by 0.54% in the pre-market trading....

Why did Atossa Therapeutics Inc. (ATOS) underperform on Thursday?

Atossa Therapeutics Inc. (ATOS) shares fell 5.38% in after-hours on Thursday, July 29, 2021, and closed the daily trading at $3.69 per share. Earlier...

Why Ardelyx Inc. (ARDX) stock price fluctuated on Thursday?

Ardelyx Inc. (ARDX) shares jumped 2.92% in after-hours on Thursday, July 29, 2021, and closed the daily trading at $1.76. Earlier in the regular...

Annovis Bio Inc. (ANVS) stock plunged during current market. Here’s the update

Annovis Bio Inc. (NASDAQ: ANVS) stock declined by 51.30% in the current market trading session. Annovis Bio based in Berwyn, Pennsylvania, is a clinical-stage...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam